Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05084196 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Melatonin for Prevention of Kidney Injury

StatusRecruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion date: Dec 31, 2027 to Jun 1, 2027v7
  2. Primary completion date: Jun 1, 2027 to Dec 31, 2027v6
  3. Primary completion date: Jun 1, 2026 to Jun 1, 2027
    • Study completion date: Dec 31, 2026 to Dec 31, 2027
    • Site contacts updated at 1 of 2 sites
    v5
  4. Study sites: 1 to 2v4
  5. Primary completion date: Jan 1, 2025 to Jun 1, 2026
    • Study completion date: Jan 1, 2026 to Dec 31, 2026
    • Eligibility criteria shortened, about 2 words
    v3
  6. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Jan 1, 2023 to Jun 5, 2023
    • Study sites: 0 to 1
    v2
  7. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study will evaluate the safety and effectiveness of melatonin for the prevention of antibiotic associated acute kidney injury in hospitalized patients.
Trial Details
NCT Number NCT05084196
Lead Sponsor Rutgers, The State University of New Jersey
Conditions
(from sponsor)		 Acute Kidney Injury, Adverse Drug Event
Related terms Acute Kidney Injury, Drug-Related Side Effects and Adverse Reactions
Enrollment 300 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov